An overview of the pharmaceutical market for Tenofovir-Emtracitabine-Efavirenz (TEE) and Tenofovir-Lamivudine-Dolutegravir (TLD) within the South African private sector

By | 15 July 2022 |

TLD: Private-sector market overview(Aug-19 to Jul-20)

For further information on TEE(Tenofovir, Emtricitabine, Efavirenz) volumes, estimates of patient numbers and payment-methods for the private-sector (Aug-19 to Jul-20) use the above link.